Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review

Ana Sá-Sousa1,2, Cidália Rodrigues3, Cristina Jácome1,2

  • 1MTG Research and Development Lab, 4200-604 Porto, Portugal.

Journal of Clinical Medicine
|September 14, 2024
PubMed

Insights

Patients with chronic obstructive pulmonary disease (COPD) face a significantly higher risk of cardiovascular disease (CVD). This systematic review highlights increased risks for conditions like heart attack and heart failure, emphasizing the need for proactive cardiovascular monitoring in COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Cardiology
  • Epidemiology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern.
  • Patients with COPD exhibit a higher prevalence of cardiovascular disease (CVD) comorbidities.
  • A comprehensive review of CVD risk in COPD patients is essential for improved patient outcomes.

Purpose of the Study:

  • To systematically review and synthesize evidence on the risk of various cardiovascular diseases in patients diagnosed with COPD.
  • To quantify the association between COPD and specific CVDs including myocardial infarction, heart failure, and stroke.

Main Methods:

  • Systematic literature search of PubMed, Web of Science, and SCOPUS databases up to September 2023.
  • Inclusion of observational studies on adult COPD patients (GOLD criteria, spirometry, or physician diagnosis) reporting CVD risk.
  • Narrative synthesis of data from 24 studies involving over 3.4 million COPD patients and 31 million controls.

Main Results:

  • Patients with COPD demonstrated a significantly higher risk of overall CVD, myocardial infarction (MI), ischemic heart disease (IHD), heart failure, and angina.
  • Elevated risks were also observed for atrial fibrillation (AF), stroke, sudden cardiac death, pulmonary hypertension, and peripheral vascular disease, though evidence varied.
  • The majority of included studies (17/24) were conducted in Europe.

Conclusions:

  • Individuals with COPD possess an elevated risk of developing cardiovascular diseases compared to the general population.
  • Close monitoring of cardiovascular risk factors and targeted interventions are crucial for managing patients with COPD.
  • This review emphasizes the need for integrated care strategies addressing both COPD and CVD management.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K